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Abstract
Arenaviruses are important causes of viral hemorrhagic fevers in humans. Arenavirus infection of cells occurs via a pH-dependent endocytic
route, but detailed studies of entry pathways have not been done. We investigated the role of cell membrane cholesterol, caveolae, and clathrin
coated pits in infection by Lassa virus (LASV), which utilizes alpha-dystroglycan (α-DG) as a receptor, and Pichindé virus (PICV), which does
not. Depletion of cellular cholesterol by treatment with methyl betacyclodextrin (MβCD) or nystatin/progesterone inhibited PICV replication and
transfer of packaged marker gene by LASVor PICV pseudotyped retroviral particles. In cells lacking caveolae due to silencing of the caveolin-1
gene, no inhibition of PICV infection or LASV pseudotype transduction was observed. However, PICV infection and LASVand PICV pseudotype
transduction was inhibited when an Eps15 dominant negative mutant was used to inhibit clathrin-mediated endocytosis. Altogether, the results
indicate that diverse arenaviruses have a common requirement for cell membrane cholesterol and clathrin mediated endocytosis in establishing
infection.
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Arenaviruses are rodent-borne, enveloped RNA viruses,
several of which cause hemorrhagic fever syndromes in humans
mainly in areas of tropical Africa and Latin America. Of the
arenavirus hemorrhagic fevers, Lassa fever is themost prevalent,
affecting approximately a quarter of a million individuals in
endemic regions of West Africa annually (Fisher-Hoch and
McCormick, 2001; McCormick et al., 1987). Because of its
capacity for person-to-person spread, the lack of practical and
readily available diagnostic tests, and limited therapeutic
options, Lassa virus is included in the list of category A priority
pathogens for biodefense research (Borio et al., 2002). Like
some other highly hazardous viruses, hemorrhagic fever-causing
arenaviruses have not been well studied; hence many basic
mechanisms of their life cycle in the infected cell have not been⁎ Corresponding author.
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doi:10.1016/j.virol.2007.07.014elucidated. In particular, significant gaps exist in the knowledge
of mechanisms of cellular uptake/viral entry, events which could
provide targets for antiviral therapeutic approaches.
Cellular entry is initiated when viruses bind cellular receptors
via their surface glycoproteins. Arenaviruses possess surface
spikes composed of trimeric GP1 subunits non-covalently
attached to a transmembrane stalk comprised of trimeric GP2
(Burns and Buchmeier, 1991; Eschli et al., 2006). GP1 is
responsible for receptor binding, whereas GP2 drives fusion of
the virion membrane with cellular membranes (Glushakova et
al., 1990; Glushakova et al., 1992). The laminin-binding protein
alpha-dystroglycan functions as a receptor for Lassa virus as well
as the prototype virus, Lymphocytic choriomeningitis virus
(LCMV) (Cao et al., 1998). The pathogenic New World
arenaviruses Junin, Guanarito, and Machupo have recently
been shown to utilize the cellular transferrin 1 receptor (TfR 1)
during viral entry (Radoshitzky et al., 2007). Arenavirus
infection is pH-dependent (Glushakova and Lukashevich,
1989), and may require GP1 dissociation from GP2 at low pH,
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Simone et al., 1994; Di Simone and Buchmeier, 1995). Unlike
the majority of viruses that exhibit pH-dependent entry, the Old
World arenavirus LCMV does not appear to utilize the clathrin-
mediated endocytic route as judged by ultra-structural studies
showing LCMV internalization into smooth-walled vesicles
(Borrow and Oldstone, 1994). However, recent evidence
implicates clathrin-mediated endocytosis for Junin virus entry
(Martinez et al., 2007).Whether the other arenaviruses utilize the
clathrin-mediated endocytic pathway remains to be determined.
It has recently been shown that depletion of cellular
cholesterol inhibits infection by the prototype arenavirus,
LCMV (Shah et al., 2006). Among the cholesterol-dependent
entry pathways, those that utilize lipid rafts or caveolae are best
studied (Marsh and Helenius, 2006; Pelkmans and Helenius,
2003). Caveolae and lipid rafts are cholesterol and glyco-
sphingolipid enriched plasma membrane microdomains that are
insoluble in non-ionic detergents and have been implicated in
modulating cell adhesion, membrane trafficking, pathogen
entry, and signal transduction (Brown and London, 1998;
Hakomori, 2000a, 2000b; Simons and Ikonen, 1997). Caveolae
are identifiable as stable invaginations of the plasma membrane
which are enriched in caveolin, a cholesterol-binding membrane
protein. Expression of caveolin 1 (cav-1) has been shown to be
sufficient to produce caveolae in cells (Lipardi et al., 1998). An
endocytic pathway leading from caveolae at neutral pH to the
smooth ER or Golgi is utilized by some viruses such as SV40
(Pietiainen et al., 2005) and Coxsackie virus B4 (Triantafilou
and Triantafilou, 2004). However, there are also examples of
pH-dependent viruses that require caveolae/lipid rafts for entry,
such as filoviruses (Bavari et al., 2002; Schornberg et al., 2006;
Takada et al., 1997).
Available experimental evidence of entry of the Old World
arenavirus LCMV therefore suggests a potentially novel pH-
dependent, cholesterol-dependent pathway. The goal of this
study was to clarify the roles of cholesterol, and caveolar or
clathrin-mediated endocytic pathways in cellular infection of
representative Old World and New World arenaviruses or their
pseudotyped surrogates. Two arenaviruses were studied: (1) the
guinea pig-passaged Pichindé virus (PICV) variant P18, which
causes hemorrhagic fever in guinea pigs (Jahrling et al., 1981;
Zhang et al., 1999), and does not utilize alpha-dystroglycan as a
receptor (Rojek et al., 2006), and (2) the Lassa-pseudotyped
murine leukemia virus (LASV-MLV), which enters by an alpha-
dystroglycan-dependent mechanism. We show that cholesterol
is required for cellular infection of PICV and the LASV-MLV
pseudotype in several relevant cell types in a caveolin-1
independent mechanism and that the effect of cholesterol
depletion on infection is at the level of entry. In addition, the
data suggests that entry of PICV and the LASV-MLV
pseudotype into host cells occurs through the clathrin-mediated
endocytic pathway.
Results
To determine whether removal of cholesterol affected the
infection of cells with the arenavirus Pichindé (PICV), plaquereduction assays and viral growth curves were performed after
treatment of cells with methyl-β-cyclodextrin (MβCD). MβCD
has been shown to remove cell membrane cholesterol (Beer et
al., 2005; Carrasco et al., 2004; Choi et al., 2005; Danthi and
Chow, 2004; Simons and Ehehalt, 2002). When Vero cells were
pretreated with MβCD prior to exposure to PICV, a 90%
reduction in plaque numbers was seen (Fig. 1A). The residual
plaques on MβCD-treated Vero cell were 29% smaller
(pb0.01) than those in untreated Vero cell cultures (data not
shown). When MβCD-treated cells were reconstituted with
cholesterol prior to the addition of virus, plaque numbers were
restored to control levels. MβCD treatment of Vero cells did not
have a significant effect on Vesicular stomatitis virus (VSV)
plaque formation. Treatment of Vero cells with nystatin/
progesterone (nys/prog), which disrupts cholesterol enriched
domains by specifically binding to cholesterol and by interfer-
ing with cholesterol synthesis, also inhibited PICV infection.
Incubating cells with nys/prog resulted in a reduction of plaque
numbers similar to that of MβCD-treated Vero cells, without
affecting VSV plaque formation (Fig. 1A). VSV infection is
known to occur via clathrin-mediated endocytosis (Sun et al.,
2005) and is not sensitive to membrane cholesterol depletion
(Danthi and Chow, 2004). This control also rules out significant
drug-induced cytoxicity.
We also studied the effect of host cellular cholesterol
depletion on PICVyield from infected cells. PICVyield at 48 h
post infection for MβCD-treated cells was reduced 70–76%
compared to untreated cells (Figs. 1B and C). This inhibition
was observed in Vero cells and P388D1 cells (a murine
macrophage-like cell line). Reconstituting cholesterol into
MβCD-treated cells prior to viral infection restored viral yield
to control levels. Pre-treating cells with nys/prog also resulted in
inhibition of PICV yield from infected Vero cells and P388D1
cells (Figs. 1B and C). Titers of VSV were unaffected by
MβCD or nys/prog treatment of Vero cells. At later time points
(72 and 96 h), after infected cells were incubated in the presence
of complete media and cholesterol containing serum, no
significant difference in PICV titers were observed between
MβCD-treated cells and untreated cells, with all cultures
generating 105–106 pfu/ml (data not shown). Approximately
85–90% of cellular cholesterol was removed by MβCD
treatment (Fig. 1D). MβCD-treated, cholesterol reconstituted
cells had slightly increased cholesterol levels when compared to
untreated control cells (Fig. 1D).
The effect of MβCD treatment on the synthesis of viral
proteins in cells infected with PICV was tested. In these
experiments, viral protein synthesis was assayed by immuno-
blot analysis using a polyclonal anti-peptide antibody GPC
(59–79) that recognizes the glycoprotein precursor GPC
(75 kDa) and GP1 (50 kDa) and a monoclonal antibody
(3B3.1) that recognizes the nucleoprotein NP (60 kDa) of PICV.
The production of the PICV GPC, GP1, and NP in MβCD-
treated Vero cells was reduced by 85–95% when compared to
untreated Vero cells at 48 h post infection (Figs. 2A and B). The
addition of cholesterol into MβCD-treated Vero cells prior to
virus infection led to an increase in the synthesis of the viral
proteins when compared to MβCD-treated Vero cells. The
Fig. 1. Effect of drug treatments on PICV infection. (A) Plaque reduction assay. Monolayers of untreated Vero cells, MβCD-treated Vero cells, cholesterol
reconstituted-MβCD-treated Vero cells, or nys/prog-treated Vero cells were infected with PICVor VSVand then overlaid for plaque assay as described inMaterials and
methods. (B) Virus yield. Untreated, MβCD-treated, cholesterol reconstituted-MβCD-treated, or nys/prog-treated Vero cells were infected with PICVor VSV at an
approximate multiplicity of infection of 1.0. At 48 h post-infection, supernatants were harvested and plaque titers determined. (C) Virus yield in P388D1 cells.
Untreated, MβCD-treated, cholesterol reconstituted-MβCD-treated, or nys/prog-treated P388D1 cells were infected with PICVat an approximate multiplicity of 1.0.
At 48 h post-infection, supernatants were harvested and plaque titers determined. (D) MβCD treatment of host cells results in the removal of cholesterol. After the
indicated treatment, cellular cholesterol was measured using the Amplex red cholesterol assay kit. Results are reported as percent cholesterol relative to untreated cells.
Results are reported as mean with standard deviation. Asterisks (⁎) indicate pb0.05 by Student's t-test.
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virus infection. These results indicated that the synthesis of viral
protein was reduced in cholesterol-depleted cells.
To determine whether cholesterol depletion primarily
inhibited early events in the viral life cycle, Vero cells were
treated withMβCD at various time points relative to the addition
of virus: 30 min prior to the addition of virus (−30); 10 min after
the addition of virus (+10); or 30 min after the addition of virus
(+30) (Fig. 3A). Immunoblot analysis was performed to assay
for viral proteins. The levels of the viral proteins NP, GPC, and
GP1were decreased when cells were treated withMβCD 30min
prior to or 10 min after the addition of virus (Fig. 3B). However,
adding MβCD 30 min after virus addition had little effect on the
amount of viral proteins produced. A corresponding reduction in
viral titers at 48 h post infection was observed (Fig. 3C).
Altogether, these data suggest that cholesterol depletion of target
cells affects early event in the virus life cycle.
To determine whether cholesterol depletion affects viral
entry per se, replication deficient arenavirus pseudotyped
retroviruses were used. We used both PICVand LASV-envelope
protein pseudotyped particles for these analyses. Retroviral
pseudotypes allowed work to be performed in a BSL-2
laboratory setting and isolated the envelope function from
other viral components and functions. To characterize the PICVand LASV-MLV pseudotypes, both the DG control hemizygous
murine ES DG(+/−) and the DG knockout murine ES DG(−/−)
cell lines (Shah et al., 2006; Zhan et al., 2005) were transduced
with the PICV and LASV env-MLV pseudotypes (Fig. 4A).
LASV (an Old World arenavirus) has been shown to infect cells
in an α-DG-dependent manner, whereas PICV (a New World
Clade A arenavirus) infection occurs independently of α-DG
(Rojek et al., 2006; Spiropoulou et al., 2002). As expected, the
LASV-MLV pseudotypes transduced the ES DG(+/−) cells
significantly better than the ES DG(−/−), which is in agreement
with other published reports (Rojek et al., 2006; Kunz et al.,
2005; Kunz et al., 2001). However, no significant difference
was observed among ES DG(+/−) and ES DG(−/−) when
transduced with the PICV-MLV pseudotype. This demonstrates
that PICV-MLV pseudotypes, similar to the Clade B human
pathogenic viruses, do not require α-DG for infection. No
difference was observed in infection of the ES DG(+/−) or ES
DG(−/−) cell lines by the control VSV-MLV pseudotype.
The PICV and LASV-MLV pseudotypes were then used to
infect MβCD-treated and untreated Vero cells (Fig. 4B). MβCD
treatment of cells prior to exposure to PICV or LASV-MLV
pseudotyped virus resulted in 95.7% and 93.0% inhibition of
transduction, respectively, when compared to untreated cells.
Furthermore, reconstitution of cholesterol in MβCD-treated
Fig. 2. Removing cellular cholesterol affects PICV protein synthesis and viral
yield. (A) Immunoblot analysis for viral proteins was performed 48 h post-
infection on untreated Vero cells, MβCD-treated Vero cells, or MβCD-treated
Vero cells reconstituted with cholesterol. (B) Densitometric values calculated by
pooling results from separate immunoblot experiments. The viral NP, GPC, and
GP1 protein values were normalized for TfR levels. The mean and standard
deviations are shown. Asterisks (⁎) indicate pb0.05 by Student's t-test.
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transduction. However, treating cells with MβCD had a
minimal effect on the entry of the pseudotyped virus bearing
the VSV-G envelope protein, as previously reported for VSV
(Shah et al., 2006; Yonezawa et al., 2005). Therefore, we
conclude that the entry of PICV and LASV requires cell
membrane cholesterol.
To test whether the entry of PICV and the LASV-MLV
pseudotype was mediated by a caveolar pathway, we utilized
human hepatoma 7 (Huh7) cells which lack functional caveolae
(Damm et al., 2005; Vainio et al., 2002). We observed that both
the LASV-MLV pseudotype and PICV infected Huh7 cells
(Table 1) as well as they infected Vero cells. In addition, Vero
cells transfected with cav-1 siRNA, resulting in the silencing of
cellular cav-1 (Fig. 5A), were readily infected by both PICVand
the LASV-MLV pseudotype (Figs. 5B and C). This demon-
strates that the LASV-MLVand PICVentry into host cells is not
primarily dependent on caveolae.
It has recently been shown that the Clade B arenaviruses
Junin, Machupo, and Guanarito bind to the cellular TfR 1
(Radoshitzky et al., 2007) during viral entry. Uptake of the
natural ligand of TfR1, transferrin, occurs via clathrin-coated
pits. Therefore, we studied the contribution of clathrin-mediated
endocytosis in arenavirus entry. EGFR pathway substrate clone
15 (Eps15) is a constituent of clathrin-coated pits and is required
for clathrin-coated pit assembly and function (Benmerah et al.,
1999). We used a dominant negative mutant of Eps15 (EΔ95/
295) which encodes a mutant Eps15 and a GFP fusion protein to
inhibit clathrin-mediated endocytosis (Benmerah et al., 1999).
Using the Amaxa Nucleofector II (as described in the Materialsand methods section), we measured 79.5±1.3% of Vero cells
that expressed GFP after transfection with the EΔ95/295 (data
not shown). We observed a significant reduction of PICV
replication in Vero cells transfected with EΔ95/295 when
compared to untreated infected-Vero cells or infected-Vero cells
transfected with the empty vector control plasmid (Fig. 6A).
VSV was used as a positive control and showed the expected
inhibition of infection in EΔ95/295-transfected cells. Immuno-
blot analysis demonstrated a reduction of PICV GPC and GP1
in Vero cells transfected with EΔ95/295 when compared to
PICV-infected cells transfected with the empty vector control
plasmid (Fig. 6B). Expression of marker gene after transduction
of cells with the LASV-MLV or PICV-MLV pseudotypes was
also reduced in EΔ95/295 transfected cells by approximately
71% and 69.8%, respectively (Fig. 6C). Examination by
fluorescent microscopy revealed that the vast majority
(98.3%) of PICV-MLV pseudotype-transduced Vero cells
(β-gal +) did not express GFP from the EΔ95/295 plasmid
suggesting that in the presence of the Eps15 DN mutant, viral
pseudotype uptake was inhibited.
We considered the possibility that the inhibitory effect of
cholesterol depletion related to inhibition of clathrin-mediated
endocytosis and transferrin-receptor uptake, although the use of
TfR as receptor by PICV has not yet been described. To
determine whether the cholesterol depletion affected clathrin-
mediated uptake of transferrin,MβCD treated cells were exposed
to fluorescent-labeled transferrin, and viewed by confocal
microscopy after 20 min. Uptake of labeled transferrin was
qualitatively diminished in MβCD-treated cells (Figs. 6D–F), as
has been previously demonstrated (Subtil et al., 1999).
Discussion
In this study, we demonstrated that cell membrane
cholesterol was required for infection of Vero and P388D1
cells by the NewWorld arenavirus PICV, given that viral protein
synthesis and viral production were inhibited when cells were
treated with MβCD or nys/prog. These effects were not due to
cytoxicity because replication of a control virus, VSV, was
unaffected by drug treatments. When cholesterol was restored in
target cells, virus replication increased to levels seen in
untreated cells. The cholesterol-depleting drug MβCD has
been shown to have additional effects on cells that can influence
events downstream of virus entry, such as inhibition of calcium
channels (Liu et al., 2006). Two lines of evidence in our study,
suggest that cellular cholesterol is required for early events in
the arenavirus life cycle: (1) when cellular cholesterol was
depleted 30 min after exposure of virus to cells, there was no
inhibition of infection and (2) cholesterol depletion inhibited
transfer of marker gene by replication defective, PICV and
LASV-MLV pseudotyped particles. Altogether, these results
demonstrate that arenavirus envelope glycoprotein-mediated
entry into host cells is dependent on the presence of cholesterol
in cellular membranes. This effect was seen in both primate
fibroblast and murine macrophage type cells. These results are
in agreement with a previously published study that reported
that cellular infection by the prototype arenavirus LCMV could
Fig. 3. Effect of timing of cholesterol depletion on PICV infection. (A) A schematic representation of the experimental layout for addition of MβCD to host cells. Cells
were treated with MβCD 30 min prior, 10 min after, or 30 min after PICV was added to host cells. (B) 48 h after infection, immunoblot analysis of the viral proteins
was performed for each of the indicated experimental conditions. Antibodies that recognize the PICV NP, GPC and GP1, and the cellular TfR were utilized. (C) Viral
titers in supernatants of MβCD-treated cells 48 h after infection are indicated. Asterisks (⁎) represent pb0.05, using Student's t-test analysis.
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Fig. 5. PICV and the LASV-MLV pseudotype enter cells through a cav-1
independent mechanism. (A) Vero cells were transfected with cav-1 siRNA or
control siRNA and infected with PICV. After 48 h, the cells were assayed by
immunoblot analysis for viral glycoprotein production, cellular cav-1, and
cellular TfR. (B) Cav-1 or control siRNA-transfected PICV cells were infected
with PICV and assayed by the Plaque reduction assay. (C) Cav-1 siRNA or
Fig. 4. The removal of cholesterol affects the entry of both the PICVand LASV-
pseudotyped virus. (A) ES α-DG(+/−) and ES α-DG(−/−) cells (solid and open
bars respectively) were infected with Env (−) MLV pseudotype, PICV-MLV
pseudotypes, LASV-MLV pseudotypes and VSV-MLV pseudotypes and β-
galactosidase positive foci were counted after X-gal staining. (B) Vero cells
treated with MβCD, or treated with MβCD, followed by cholesterol
reconstitution. Following drug treatment, cells were exposed to diluted stocks
of indicated pseudotyped MLV preparation, and colony forming units (CFU)
were counted after X-gal staining. The means and standard deviation of triplicate
wells are indicated. Each experiment was repeated at least 3 times. Using
Student's t-test, the ⁎ represents a pb0.05.
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extended this observation to arenaviruses that are macrophage-
tropic and cause primarily hemorrhagic fever syndromes in
susceptible hosts. The effect was similar for LASV-MLV
pseudotype, which utilizes α−DG as receptor, and PICV (virus
and pseudotype), which does not (Rojek et al., 2006). We have
also shown for the first time that PICV and LASV pseudotypes
were capable of infecting cells devoid of caveolin-1, indicatingcontrol siRNA-transfected cells were infected with the LASV-MLV pseudotype
and assayed for β-galactosidase positive foci.
Table 1
Cells were infected with the LASV-MLV pseudotype for 48 h and infection was
quantified by counting galactosidase expressing foci after X-gal staining
LASV-MLV pseudotype infection of various cells
Cell line Virus Infection (CFU±S.D.)
Vero LASV-MLV 1860±396
Huh7 LASV-MLV 2050±487
Huh7-MBCD LASV-MLV 205±33
Huh7-nys/prog LASV-MLV 198±37
PICV titres in Huh7 cells after 48 h of infection
Cell line Virus Titer (×105 pfu/ml)
Vero PICV 4.0
Huh7 PICV 5.6
Huh7-MBCD PICV 0.53
Huh7-nys/prog PICV 0.49
Huh7 cells infected with PICV (MOI=1) for 48 h. The virus containing
supernatant was harvested and plaque titers were determined using Vero cells.that arenaviruses enter cells by a non-caveolar pathway. This is
consistent with previous ultra-structural studies of LCMVentry
which suggested that virus-containing smooth walled endocytic
vesicles were 150–300 nm in diameter (Borrow and Oldstone,
1994), which is typically bigger than caveolae (Raznani et al.,
2002). We cannot rule out the possibility that multiple entry
pathways may be used simultaneously by arenaviruses, as has
been previously shown for SV40 (Damm et al., 2005).
Mechanisms by which cholesterol may be involved during
viral entry include virus binding to cellular receptor(s) that are
localized within lipid raft microdomains, which includes
caveolae and non-caveolar cholesterol-enriched domains. For
example, the HIV-1 CD4 primary receptor is constitutively
associated with lipid rafts and can be detected within detergent
insoluble fractions of lysed cells (Kozak et al., 2002; Millan et
al., 1999). The disruption of lipid rafts by cholesterol removal
Fig. 6. PICVand the PICV-MLVandLASV-MLVpseudotypes enter host cells through the clathrin-dependent pathway. (A)Vero cells were transfectedwith EΔ95/295 or
the empty vector-control plasmid and infected with PICVor VSV 48 h post transfection. After 48 h, the supernatants were collected and viral titers were determined by
plaque assay. (B) Vero cells, control plasmid-transfected Vero cells, or EΔ95/295-transfected Vero cells were infected with PICV for 48 h and viral glycoprotein
production was assayed by immunoblot analysis. The last lane represents the PICV GPC and GP1 control to demonstrate the size of the viral proteins. (C) LASV-MLV,
VSV-MLV, and PICV-MLVpseudotypes were used to transduceVero cells, Vero cells transfectedwith EΔ95/295, or Vero cells transfectedwith the control plasmid. CFU
in each well were counted after X-gal staining. The means and standard deviations are indicated and the ⁎ represents a pb0.05 by the Student's t-test. (D) Untreated Vero
cells or Vero cells treated with (E) MβCD or (F) nys/prog were incubated with Tf-594 for 20 min followed by 4% paraformaldehyde fixation and confocal microscopy.
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cellular membrane and reduces the opportunity for multiple
receptor interactions that enhance virus uptake. Alternatively,
viral receptors may transiently associate with lipid rafts/caveolae
after being engaged by viral ligand and this may be important
for viral endocytosis (Triantafilou and Triantafilou, 2004).
Although not well studied, there is currently no evidence that
arenavirus receptors are localized to lipid rafts. GPI-linked
proteins, which tend to be localized and concentrated in lipid
rafts, do not serve as viral receptors for the New World
arenaviruses (Rojek et al., 2006). The TfR 1, which has been
recently identified as the receptor for some New World
arenaviruses, is not constitutively localized to lipid rafts (Harder
et al., 1998). α-DG (LCMV receptor) or its cellular partner
β-DG are not present in detergent insoluble domains of sus-ceptible cells, even after LCMVbinds to cells (Shah et al., 2006).
This conclusion is weakened by the lack of studies using labeled
LCMV to show translocation to lipid raft or non-lipid raft
fractions. Additional limitations of the study include insufficient
sensitivity of the assay to detect small but relevant amounts of
α-DG, variations of protein-lipid raft association depending on
the state of the cells (Kusumi and Suzuki, 2006), and the
detergent utilized to isolate detergent insoluble domains (Schuck
et al., 2006). However, our observation that arenavirus infection
did not require caveolae supports the conclusions of Shah et al.
in that caveolae are normally associated with lipid raft domains.
Since the New World arenaviruses Guanarito, Junin, and
Machupo utilize the TfR 1 as their receptor (Radoshitzky et al.,
2007), and since the TfR 1 is known to translocate from the
cellular surface to endosomes via clathrin-coated pits, we
8 E.M. Vela et al. / Virology 369 (2007) 1–11investigated the role of clathrin-mediated endocytosis in virus
entry. We observed substantial inhibition of PICV infection in
cells that were transfected with an Eps15 DN mutant (EΔ95/
295). Infection with VSV, used as a control to ensure the
effective inhibition of the clathrin-mediated uptake by this
dominant negative mutant protein, was also diminished in
transfected cells. We also observed that transduction of cells by
the LASV-MLV or PICV-MLV pseudotypes was significantly
reduced in cells which expressed the Eps15 DN mutant. This
was demonstrated both by substantially reduced titers of β-gal
expressing pseudotypes in EΔ95/295-transfected Vero cell
monolayers, and by the observation that those few cells that did
express the marker gene β-gal generally did not express the
mutant Eps15-GFP fusion protein. Therefore, we believe that
reduced infection/transduction in EΔ95/295 transfected cells is
largely occurring in cells that maintain functional Eps15. The
finding of small number of double positive (β-gal/GFP) cells
suggests that an alternate, non-clathrin pathway may support
viral entry to a limited degree.
Cellular uptake of labeled transferrin, a marker for clathrin
mediated endocytosis and for the trafficking of a putative New
World arenavirus receptor, was diminished after cholesterol
depletion of cells. However, drug treatment in host cells did not
affect total TfR levels as determined by immunoblot analysis.
Classically, viruses that utilize the clathrin-mediated endosomal
entry pathway are less sensitive to cholesterol depletion than
viruses that utilize caveolae or lipid rafts during entry. However,
studies have demonstrated that cholesterol depletion of cells
affects the morphology of clathrin-coated pits and inhibits the
detachment of coated pits from the plasma membrane during
clathrin-mediated endocytosis (Subtil et al., 1999). Overall, this
suggests that PICVenters cells through clathrin-coated pits and
that cholesterol depletion may inhibit entry by inhibiting
clathrin-coated pit internalization. While this manuscript was
in review, a new study demonstrated that the New World
arenavirus Junin enters cells through clathrin-mediated endo-
cytosis, in agreement with our findings (Martinez et al., 2007).
However, this study concluded that Junin entry is only
moderately inhibited in the presence of nystatin and MβCD
(20–40%). It is possible for Junin virus, a Clade B arenavirus,
and PICV, a Clade A arenavirus, to have similar routes of entry
but differ in their sensitivity to cholesterol depletion.
Our findings of clathrin-mediated entry is at variance with
older utrastructural studies of the Old World arenavirus LCMV,
which suggested that LCMVenters cells through smooth-walled
vesicles rather than coated pits (Borrow and Oldstone, 1994).
Our data, taken in context with the existing literature, suggests
the possibility that different Old World arenaviruses may enter
cells through different entry pathways. It is also possible for
these arenaviruses to utilize different endosomal mechanisms
during entry into different cell types, some of which may lead to
non-productive infection. β-DG, the cytoplasmic partner for the
Lassa virus receptor α-DG, has been shown to interact with the
GTPase dynamin at membrane ruffles (Zhan et al., 2005). The
results from that study suggest a role for dystroglycan in
regulating the clathrin-mediated endocytosis of transferrin.
However, LCMV binding and infection of cells is not dependenton β-DG (Kunz et al., 2003). These results suggest that although
β-DG is not required for arenavirus entry, clathrin-mediated
endocytosis is required. Intermediary events initiated by TfR1
and α-DG binding by different arenaviruses need to be studied.
Altogether, our data demonstrate that PICVand the LASV-MLV
pseudotype enter host cells through a cholesterol-dependent,
caveolin-independent, clathrin-mediated endocytic pathway.
The alphavirus Semliki Forest virus (SFV) entry into host cells
is mediated by the clathrin-dependent endocytosis and has been
shown to be sensitive to cholesterol depletion (Kolokoltsov et al.,
2006) and it has been reported that cholesterol and sphingolipid
is required for SFV fusion with host cells independently of lipid
rafts (Ahn et al., 2002; Waarts et al., 2002). We propose that the
entry of PICVand the LASV-MLV pseudotype is similar to SFV
in that entry of all are sensitive to cholesterol depletion and
mediated by clathrin-dependent endocytosis. These findings
may result in the design of therapeutics aimed at blocking the
early stages of arenavirus entry.
Materials and methods
Cell lines, reagents, and viruses
Vero cells were maintained in minimal essential medium
(Cellgro, Mediatech, Inc., Herndon, VA) supplemented with 5%
heat-inactivated fetal bovine serum (Hyclone, Logan, UT),
10 mM of HEPES, and 100 U/ml of penicillin and 100 μg/ml of
streptomycin (Gibco BRL, Invitrogen, Carlsbad, CA). The Vero
cells were used between passages 10 and 40. Huh7 cells were
maintained in minimal essential medium supplemented with
10% heat-inactivated fetal bovine serum, 10 mM of HEPES, and
100 U/ml of penicillin and 100 μg/ml of streptomycin The
murinemacrophage-like P388D1 cells weremaintained in RPMI
(Gibco BRL) supplemented with 5% heat-inactivated fetal
bovine serum and 100 U/ml of penicillin and 100 μg/ml of
streptomycin. 293FT cells were maintained in DMEM supple-
mented with 10% FBS and 100 U/ml of penicillin and 100 μg/ml
of streptomycin. Mouse embryonic stem cells deficient in α-DG
(ES DG −/−) and hemizygous for α-DG (ES DG +/−) were a gift
from S. Carbonetto (McGill University Health Centre, Montreal,
Quebec) and were maintained in DMEM with 10% FBS,
100 U/ml of penicillin and 100 μg/ml of streptomycin, 1%
nonessential amino acids, 2 mM L-glutamine, 0.1 mM β-merca-
ptoethanol, and 1000 U/ml of ESGRO, a serum-free culture
medium that contains BMP4 and the cytokine leukemia
inhibitory factor (LIF) obtained fromChemicon (Temecula, CA).
Guinea pig-passaged variants of PICV strain CoAn 4763
were developed by Peter Jahrling (Jahrling et al., 1981). The
high-passage virulent PICV-P18 (Zhang et al., 1999) was
utilized at an MOI of 1 for all infection experiments. Vesicular
stomatitis virus-Indiana strain (VSVIndiana) was a gift from T.
Jerrells (University of Nebraska Medical Center, NE).
Chemical treatment of cells
Cells were treated with 5 mM methyl-β-cyclodextran
(MβCD) (Sigma-Aldrich, St. Louis, MO) diluted in serum-
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vigorously washed 3× with PBS to remove any chemicals prior
to incubation with virus. In some experiments, cells were treated
with 0.03 mM of both nystatin and progesterone (Sigma-
Aldrich) overnight prior to infection, washed, and infected with
virus for 20 min. After the virus incubation stage, media
containing nystatin/progesterone was added. Nystatin/proges-
terone was present for the duration of the experiment post-viral
binding. For cholesterol reconstitution experiments, cholesterol
(Sigma-Aldrich) diluted to a final concentration of 0.25 mM in
DMEM with 5% FBS, was added to cholesterol-deficient cells
for 1 hr at 37 °C. The cells were washed 3× prior to the addition
of virus.
Cholesterol assay
Cells were harvested and washed 3x with PBS prior to
measuring the amount of cellular cholesterol. The cholesterol
content in 105 cells was measured using the Amplex Red
Cholesterol Assay (Molecular Probes, Invitrogen) as directed
by the manufacturer. Fluorescence was measured with a BioTek
Synergy HT fluorescent platereader at 530–560 nm and
equipped with BioTek KC4 software and the amount of cellular
cholesterol was calculated by comparing the fluorescence
obtained from the samples to the fluorescence obtained from
the standard curve.
Expression plasmid vector constructs
pGAG-POL which encodes the MLV gag and polymerase
(Kolokoltsov et al., 2005), the Eps15 DN mutant (EΔ95/295),
and the empty vector control plasmid (pLenti6/V5-D-Topo,
Invitrogen) (Kolokoltsov et al., 2006) were gifts from Dr. R.
Davey (UTMB, Galveston, TX). pψ β-gal plasmid was used as
a marker gene construct (Strategene, La Jolla, CA), and encodes
β-galactosidase flanked by the MLV-LTR and packaging
sequences. pVSV-G encoding VSV-G under the control of the
CMV immediate-early promoter was purchased from Clonetch
(Palo Alto, CA). pLGP which encodes the LASV(Josiah) GPC
envelope ORF in the pCMV-β vector was a gift from M.
Buchmeier (The Scripps Research Institute, CA).
Constructs encoding the PICV P18 envelope were created by
replacing the β-gal ORF in pCMV-β (Clontech, Mountain
View, CA) with the PICV glycoprotein precursor (GPC) ORF,
hence this construct was analogous to pLGP. The P18 GPC
sequences were first cloned into pcDNA3.1/V5-His Topo
(Invitrogen). PICV P18 GPC insert flanked by NotI (5′) and
SalI (3′) restriction sites was generated by PCR using the
following primers: forward (5′ CGTACTGCGGCCGCATGG-
GACAAGTTGTGACTTTGATCCAG 3′) and reverse (5′
CTAGGCGTCGACTTATTTACCCAGTCTCACCC 3′)
(restriction sites underlined). The gel purified PICV-GPC
PCR products were digested with NotI and SalI to generate
NotI hanger at the 5′ end and the SalI hanger at the 3′ end.
The PCR fragment was purified (Qiagen, Valencia, CA), and
ligated into pCMV-β, in which β-gal ORF was previously
removed by NotI and SalI digestion. After transformation ofTopo competent cells (Invitrogen), plasmids were isolated and
inserts were confirmed by DNA sequencing.
Generation of arenavirus envelope pseudotyped MLV particles
Replication incompetent retroviral pseudotypes expressing
either the LASV envelope glycoproteins, the PICV envelope
glycoproteins, or the VSV-G envelope were produced following
methods similar to those published elsewhere (Kolokoltsov et
al., 2005). 293FT cells were plated 1 day prior to transfection at
a concentration of 3×105 cells per well (in a 6 well plate). The
next day, 6 μl of TransIT-LT1 transfection reagent (Mirus
Corporation) was added to 200 μl of serum-free media
(DMEM), gently mixed, and incubated for 20 min at room
temperature. Plasmid DNA, purified by cesium gradient or
Qiagen kit, was added to TransIT-LT1 mixture (total 2 μg DNA,
1:1:1 ratio pGAG-POL: pψ β-gal: envelope plasmid) and
incubated for 20 min at room temperature. The TransIT-LT1/
DNA complex was then added to the 293FT cells, gently mixed,
and incubated for 48 h at 37 °C. The supernatant was harvested
and filtered through a 0.45 μm filter (GE Osmonics Laboratory)
to remove cellular debris. The pseudotype titer was determined
by incubating Vero cells with virus-containing culture super-
natants and staining cells after 48 h with X-gal solution (0.05 M
potassium ferrocyanide and potassium ferricyanide, 2 mM
X-gal, and PBS) for 2 h. β-Galactosidase positive foci were
counted and expressed as colony forming units (CFU). As a
control, transfections were also performed by omitting envelope
plasmid.
Immunoblot blot analysis of PICV-infected cells
Immunoblot assays for viral protein synthesis were per-
formed using standard methods on PICV-infected and unin-
fected cells. As primary antibodies, the following reagents were
used: (1) mouse monoclonal antibody 3B3.1 recognizing the
PICV nucleoprotein (NP) (Buchmeier et al., 1981) (donated by
Dr. M. Buchmeier, The Scripps Research Institute, CA); (2)
polyclonal rabbit anti-peptide antibody GPC(59–79) raised
against the LCMV-ARM GPC sequence recognizing the PICV
and LASV GPC/GP1 (donated by Dr. M. Buchmeier, The
Scripps Research Institute, CA) (Buchmeier et al., 1987); and
(3) anti-transferrin receptor (TfR) antibody (H68.4) (Zymed
Laboratories, Inc., San Francisco, CA). After washing steps and
incubation with appropriate HRP-conjugated secondary anti-
body, signal was developed using the SuperSignal West Femto
(Pierce Biotechnology, Inc., Rockford, IL) as the substrate.
Densitometry was performed on at least three immunoblot
experiments using the OneD-scan program (Scanalytics, a
division of CSPI, Billerica, MA). The viral protein band
intensities were normalized to TfR expression levels.
Transfection of Vero cells with siRNA or dominant negative
mutants
Vero cells were transfected using the Nucleofector II gene
transfer device (Amaxa, Gaithersburg, MD). Cav-1 siRNA,
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EΔ95/295, or the empty vector control plasmid was added to
the nucleofector siRNA transfection solution or transfection kit
V solution and transferred to 1.0×106 Vero cells as instructed
by the company. The cells were then transferred to the
Nucleofector II gene transfer device and electroporation
occurred using the program V-001. The cells were then
removed and transferred to 6-well plates and incubated for
24 h at 37 °C prior to any infection or protein expression
analysis. Cav-1 expression was assayed by Immunoblot
analysis using rabbit polyclonal Cav-1 antibody (N-20) (Santa
Cruz Biotechnology). We observed GFP expression in 84.6% of
transfected Vero cells using an eGFP plasmid provided by the
company. Transfections of Vero cells with the EΔ95/295–GFP
fusion plasmid resulted in GFP expression in 79.5% of cells.
Plaque assay
Drug-treated and untreated Vero cell monolayers were
infected with PICV for 30 min at 37 °C in a 5% CO2 humidified
atmosphere in serum-free MEM, followed by 3 washes with
PBS to remove any unbound virus. Fresh complete MEM
containing 5% FBS was added and the cells were incubated for
48 h at 37 °C. The virus-containing supernatant was collected at
48 h, 72 h, or 96 h, filter sterilized to remove any cellular debris,
and a standard plaque assay was performed on Vero cells to
measure virus production. Briefly, monolayers were exposed
to virus for 30 min, after which monolayers were overlaid with
3 ml of methylcellulose containing 2x Eagle's minimal essential
media (EME), 2% FBS, and 1% methylcellulose for 96 h.
Neutral Red overlay containing 0.12 mM of Neutral Red
(Sigma Aldrich) was added to the monolayers for 24 h and the
plaques were counted.
For the plaque reduction assay, drug-treated or untreated
Vero cells were infected with 100 μl of PICV stock in a 6 well
plate for 45 min at 37 °C. After inoculum was removed,
monolayers were overlayed with methyl-cellulose-containing
overlay and plaque assays were performed directly as described.
Plaque numbers and sizes were recorded.
Confocal microscopy
Vero cells were incubated with Tf-594 (Molecular Probes)
for 20 min prior to 4% paraformaldehyde fixation. The cells
were washed 3× to remove any paraformaldehyde and slides
were prepared using SlowFade® Gold antifade reagent with
DAPI (Molecular Probes) for nuclear staining. The Zeiss LSM
510 Meta Confocal microscope with ×63 objective was utilized.
To visualize DAPI, excitation at 351 nm and 364 nm was
utilized and excitation at 543 nm was used to visualize Tf-594.
Zeiss LSM imaging software was used to analyze the images.
Statistical analysis
The results were expressed as averages±standard deviation.
Statistical significance was assessed by Student's t-test and
statistical significance was ascribed when pb0.05.Acknowledgments
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